Literature DB >> 31933499

A Method for Examining the Equating of Psychometric Scales and Tests: An Application Using Dementia Screening Test Batteries.

N Maritza Dowling1, Tenko Raykov2, George A Marcoulides3.   

Abstract

Equating of psychometric scales and tests is frequently required and conducted in educational, behavioral, and clinical research. Construct comparability or equivalence between measuring instruments is a necessary condition for making decisions about linking and equating resulting scores. This article is concerned with a widely applicable method for examining if two scales or tests cannot be equated. A latent variable modeling method is discussed that can be used to evaluate whether the tests or parts thereof measure latent constructs that are distinct from each other. The approach can be routinely used before an equating procedure is undertaken, in order to assess whether equating could be meaningfully carried out to begin with. The procedure is readily applicable in empirical research using popular software. The method is illustrated with data from dementia screening test batteries administered as part of two studies designed to evaluate a wide range of biomarkers throughout the process of normal aging to dementia or Alzheimer's disease.
© The Author(s) 2018.

Entities:  

Keywords:  dementia screening test; equating; latent construct; latent structure; latent variable modeling; necessary condition; scale; sufficient condition; test battery

Year:  2018        PMID: 31933499      PMCID: PMC6943986          DOI: 10.1177/0013164418775785

Source DB:  PubMed          Journal:  Educ Psychol Meas        ISSN: 0013-1644            Impact factor:   2.821


  9 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Improving precision in the quantification of cognition using the Montreal Cognitive Assessment and the Mini-Mental State Examination.

Authors:  Lisa Koski; Haiqun Xie; Susanna Konsztowicz
Journal:  Int Psychogeriatr       Date:  2011-02-01       Impact factor: 3.878

3.  The Montreal Cognitive Assessment: validity and utility in a memory clinic setting.

Authors:  Tasha Smith; Nadia Gildeh; Clive Holmes
Journal:  Can J Psychiatry       Date:  2007-05       Impact factor: 4.356

4.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

5.  Examining Population Differences in Within-Person Variability in Longitudinal Designs Using Latent Variable Modeling: An Application to the Study of Cognitive Functioning of Older Adults.

Authors:  N Maritza Dowling; Tenko Raykov; George A Marcoulides
Journal:  Educ Psychol Meas       Date:  2018-02-23       Impact factor: 2.821

6.  Do Two or More Multicomponent Instruments Measure the Same Construct? Testing Construct Congruence Using Latent Variable Modeling.

Authors:  Tenko Raykov; George A Marcoulides; Bing Tong
Journal:  Educ Psychol Meas       Date:  2015-09-17       Impact factor: 2.821

7.  Examining Construct Congruence for Psychometric Tests: A Note on an Extension to Binary Items and Nesting Effects.

Authors:  Tenko Raykov; George A Marcoulides; Dimiter M Dimitrov; Tatyana Li
Journal:  Educ Psychol Meas       Date:  2016-06-23       Impact factor: 2.821

8.  Mini-mental State Examination performance in mild cognitive impairment subtypes.

Authors:  Breno S O Diniz; Monica S Yassuda; Paula V Nunes; Marcia Radanovic; Orestes V Forlenza
Journal:  Int Psychogeriatr       Date:  2007-05-14       Impact factor: 3.878

9.  Measuring cognition in a geriatric outpatient clinic: Rasch analysis of the Montreal Cognitive Assessment.

Authors:  Lisa Koski; Haiqun Xie; Lois Finch
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-03-23       Impact factor: 2.680

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.